The North America Nanotechnology in Medical Devices Market which is a USD 3032 Million market in 2018 is poised reach USD USD 5334 Million by the year 2023 with an impressive growth rate of 12% in the forecasted period. Nanotechnology have witnessed significant growth in last decade owing to its potentiality to reform the healthcare services. With the advancements in technology and increasing prevalence of diseases with the aging population, the market is expected to prosper in the future.
Nanotechnology based medical devices involves dimensions that are tiny fractions of the width of a human hair and is set to revolutionise the healthcare sector. With many nanotechnology applications in the pipeline, it offers many exciting opportunities and is believed to detect and treat the human body damages in the future.
The nanotechnology medical device market is driven by a list of factors that include increasing investment by government in nanotechnology, availability of insurance coverage, reimbursement for healthcare expenditure, growing healthcare expenditure and rising aging population. There are also a few restraints the market has to overcome in order to sustain in the future which includes stringent regulatory policies and high cost involving nanotechnology.
The North America nanotechnology in the medical device market is divided based on the type of the product as implantable material, active implantable material, medical textile and wound dressing and biochips. The implantable material is further divided into dental filling and restorative material. While the active implantable material is divided into cardio rhythm management devices, hearing aid rhythm and rental implants. On the basis of application, the market is segmented as diagnostics, research and therapeutics applications. Based on geography, the market is analysed under regions of US and Canada.
The major player in the nanotechnology industry that are manufacturing medical devices are 3M Company, Stryker Corporation, Acusphere, Inc., AMAG Pharmaceutical, St. Jude Medical, Inc., Affymetrix, Inc., PerkinElmer, Inc., Smith & Nephew, Inc. and Starkey Hearing Technologies.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modeling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 United States
6.3 Canada
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
